Evaluation Of The GE Monitor Product Line
Withdrawn
- Conditions
- RespirationECGTemperatureSpO2Non-invasive Blood Pressure
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2017-08-08
- Lead Sponsor
- GE Healthcare
- Registration Number
- NCT00730119
- Locations
- 🇺🇸
GE Healthcare, Tampa, Florida, United States
Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma
- Conditions
- Neuroblastoma
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2009-11-09
- Lead Sponsor
- GE Healthcare
- Registration Number
- NCT00730444
- Locations
- 🇺🇸
GE Healthcare, Princeton, New Jersey, United States
A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice.
Phase 4
Completed
- Conditions
- Echocardiography
- Interventions
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2012-06-12
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 1039
- Registration Number
- NCT00730964
- Locations
- 🇺🇸
GE Healthcare, Princeton, New Jersey, United States
Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages
Completed
- Conditions
- Arteriosclerosis Obliterans
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2011-04-28
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 103
- Registration Number
- NCT00712946
- Locations
- 🇫🇮
Department of Anesthesiology and Intensive Care, Turku University Hospital, Turku, Finland
Comparative Study of Phototherapy for Hyperbilirubinemia
Not Applicable
Completed
- Conditions
- Hyperbilirubinemia
- Interventions
- Device: LED fiberoptic blanket phototherapy (BiliSoft blue LED fiberoptic blanket phototherapy)Device: Metal halide phototherapy (Spot PT metal halide phototherapy)Device: LED bank phototherapy (Natus neoBlue LED bank phototherapy)Device: Metal halide plus LED fiberoptic blanket phototherapy (BiliSoft and Spot PT)
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2009-01-13
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 82
- Registration Number
- NCT00635375
- Locations
- 🇺🇸
Christiana Hospital, Newark, Delaware, United States
🇺🇸University of Tennessee, Knoxville, Tennessee, United States
Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
Completed
- Conditions
- Bladder Cancer
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2014-08-25
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 283
- Registration Number
- NCT00634621
- Locations
- 🇪🇸
GE Healthcare, Madrid, Spain
SuperSTAT Noninvasive Blood Pressure Monitor Evaluation
- Conditions
- Non-Invasive Blood Pressure
- First Posted Date
- 2008-01-29
- Last Posted Date
- 2008-07-23
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 20
- Registration Number
- NCT00603486
- Locations
- 🇺🇸
GE Healthcare, Tampa, Florida, United States
A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
Phase 2
Completed
- Conditions
- Lung CancerSarcomaHigh-grade GliomaMelanomaHead & Neck Cancer
- Interventions
- Drug: Fluciclatide Injection - (AH111585 (F18))
- First Posted Date
- 2007-11-30
- Last Posted Date
- 2014-08-18
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 33
- Registration Number
- NCT00565721
- Locations
- 🇺🇸
GE Healthcare Office, Princeton, New Jersey, United States
Test of Digital Breast Tomosynthesis vs. Common Mammography to Detect Breast Cancer for Women Undergoing Breast Biopsy
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2012-03-22
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 220
- Registration Number
- NCT00535184
Test of Digital Breast Tomosynthesis vs. Regular Mammography in Detecting Breast Cancer in Women Undergoing Diagnostic Mammography
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2010-05-14
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 220
- Registration Number
- NCT00535327